Everest Group Names Medidata a "Leader" and "Star Performer" in Decentralized Clinical Trial Platforms

Medidata recognized for continued growth in market impact and vision in 2023 ‘Everest Group PEAK Matrix Assessment’

  • Medidata Sensor Cloud noted as a strength for unifying data on a single data platform
  • Circuit Clinical partnership important to enhancing expertise across therapy areas
  • Project management capabilities cited by clients as a key differentiator
  • Governance, security, and compliance are among Medidata’s highly rated offering

New York – December, 13 2022 – Medidata, a Dassault Systèmes company, has been  named a Leader and Star Performer in the “Decentralized Clinical Trial Platforms PEAK Matrix Assessment 2023” by Everest Group. The annual report evaluates decentralized clinical trial (DCT) products from 24 companies based on vision, capability, and market impact.

“Medidata provides a modular DCT platform with a unified data layer. Its solution is highly recognized for governance, security, and compliance by clients,” said Chunky Satija, vice president at Everest Group. “Medidata’s investments towards standardizing the site operations, improving the ease of use of the platform, expanding access to clinical trials, and unifying reporting from a single data platform have put Medidata into a leader’s position in the decentralized clinical trial platforms PEAK Matrix Assessment.” 

Leaders in the DCT Platforms PEAK Matrix Assessment:

  • Offer clients an end-to-end modular platform with a unified data model that allows all patient data to be in a single repository, eliminating data silos
  • Provide the auxiliary services required to run a DCT
  • Are ranked high on user and patient experience, and they offer advanced use cases to clients (such as advanced analytics and patient recruitment campaigns) to enable them to run their DCTs
  • Work proactively toward building market awareness and stakeholder education via various forums and enjoy high mindshare and brand perception

“As the industry has evolved and demand for DCTs has grown, Medidata has been at the forefront of driving innovation for patient-centric technologies.” said Anthony Costello, CEO of Medidata Patient Cloud. “Recognition from Everest as both a Leader and Star Performer validates the success we have gained with our sponsors and CROs. Our depth and breadth of solutions across therapy areas, and our project management capabilities were key to earning our spot as a Leader,” 

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 33,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,200+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit https://www.3ds.com